RXRX Recursion Pharmaceuticals Inc

USD 7.84 -0.10 -1.259446
Icon

Recursion Pharmaceuticals Inc (RXRX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 7.84

-0.10 (-1.26)%

USD 1.72B

4.38M

USD 14.60(+86.22%)

USD 11.00 (+40.31%)

Icon

RXRX

Recursion Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 7.84
0.00 0
Take a Tour

Recursion Pharmaceuticals Inc (RXRX) Stock Forecast

Show ratings and price targets of :
USD 14.60
(+86.22%)

Based on the Recursion Pharmaceuticals Inc stock forecast from 3 analysts, the average analyst target price for Recursion Pharmaceuticals Inc is USD 14.60 over the next 12 months. Recursion Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Recursion Pharmaceuticals Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Recursion Pharmaceuticals Inc’s stock price was USD 7.84. Recursion Pharmaceuticals Inc’s stock price has changed by +5.95% over the past week, -25.55% over the past month and +51.64% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...